Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer
Status:
Terminated
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Investigators propose to study the effect of panitumumab when combined with an active
regimen, such as DCF (Docetaxel/Cisplatin/Fluourouracil), in previously untreated patients
with advanced cancer of the stomach.